Our Goal: Reduce Strokes
The Cerebrovascular Disease and Stroke Center at the University of Cincinnati Neuroscience Institute (UCNI) has developed a new Carotid Disease Assessment Program to reduce the incidence of stroke in the Greater Cincinnati-Northern Kentucky region.
Approximately 38,000 strokes are attributed to carotid artery disease annually in the United States. Carotid artery disease (also called carotid stenosis) is a narrowing of the carotid arteries, the two major arteries that carry oxygen-rich blood from the heart to the brain. This narrowing is caused by a buildup of plaque inside the artery wall that reduces blood flow to the brain.
Recent published studies have confirmed that rapid treatment of carotid artery disease can greatly reduce the risk of stroke.
Our program provides rapid assessment and treatment for patients with carotid disease. Features of the program include:
- A coordinated evaluation by a Stroke Team neurologist and the surgery/interventional team, with rapid feedback to the referring physician
- A multidisciplinary team that includes specialists in neurology, neuroradiology, neurosurgery and vascular surgery
- Treatment plans that include the full complement of medical, surgical, interventional and preventative treatment options
- Access to a broad range of clinical trials
UCNI’s primary stroke center, one of the nation's most prominent stroke programs, is supported by a nationally recognized neurocritical care program and state-of-the-art facilities.